Increased levels of NSE have also been reported in a variety of other neurological disorders including Guillain‐Barré syndrome and cerebral trauma as well as specific neuroendocrine tumors (Isgrò et al., 2015). The gene discussed is ENO2; the disease is neuroendocrine neoplasm.